An interview with MATTER CEO Steven Collens and his outlook on technology-driven solutions for healthier aging and health care.
Medtech innovation for the aging world
The operating room of the future
Building value through creative deal structures
Investing in China for the long term
Two-Invoice Policy: A Paradigm Shift in China’s Medical Devices Industry
How the genius of technology is transforming health care
Creating a framework for future medtech innovation
Oncology R&D driving strategic transformation
Finding sustainability in biotechnology, pharmaceutical and medical technology
Amplified business decisions are the new norm thanks to rapid changes. From new market entrants and regulatory reform to expiring patents and the growing challenge of chronic diseases, leaders in the life sciences community must explore a new course to address the changing climate for health care — one driven by patients and focused on health outcomes.
Our Global Life Sciences Center brings together a worldwide team of professionals to help you achieve your potential.
We cover key issues in these areas:
Connect with us
Stay connected with us through social media, email alerts or webcasts. Or download our EY Insights app for mobile devices.
Following the two-invoice policy roll-out for pharma, one can expect this will pose similar impacts on MedTech stakeholders.
Have investor-friendly capital allocation and new competitors upended the world order in M&A? Find out how the biopharma sector is facing this challenge.